Status:
COMPLETED
The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes
Lead Sponsor:
University of Roma La Sapienza
Collaborating Sponsors:
Campus Bio-Medico University
Ospedale Sandro Pertini, Roma
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Brief Summary
This observational study is aimed at identifying new molecular promoters of mortality (and morbidity) in patients with type 2 diabetes mellitus (T2DM).
Detailed Description
Background Mortality rate of diabetic patients is about twice as much that of non-diabetic individuals of similar age; this makes diabetes a leading risk factor for mortality, especially of cardiovasc...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus
Exclusion
- Severe psychiatric illnesses
- End-stage renal disease and dialysis
- Cirrhosis
- Any active cancer
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
5139 Patients enrolled
Trial Details
Trial ID
NCT02311244
Start Date
January 1 2014
End Date
December 1 2022
Last Update
May 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Roma La Sapienza
Rome, RM, Italy, 00161